Lundbeck Canada

At Lundbeck Canada, we strive to improve the lives of Canadians with brain diseases.


Lundbeck Canada is a subsidiary of H. Lundbeck A/S, an international research-based pharmaceutical company focused on brain diseases. Based in Montreal, Lundbeck Canada has been active in the Canadian pharmaceutical industry for over two decades, marketing products for the treatment of brain diseases such as depression, anxiety, Alzheimer’s disease, schizophrenia and bipolar disorders.

Through research, development, education, and partnerships with other companies and patient organizations, Lundbeck employees aim to improve the quality of life for people living with brain diseases.

According to Montreal’s Top Employers 2017, Lundbeck Canada’s employees feel “we are not just doing a job, but making a positive contribution to the world around us.” Even with a staff of approximately 150 employees, everyone feels like they belong to an organization that cares about them and their local community.

Learn more about our history in Canada.

About Lundbeck Worldwide

Read more on our H. Lundbeck A/S website

Our Unique Ownership Structure

The Lundbeck Foundation is one of Denmark’s largest commercial foundations and Lundbeck’s largest shareholder – owning 70 percent of the company.

Read more on our H. Lundbeck A/S website

You are now leaving , Lundbeck Canada’s Web site. Links to site outside of Lundbeck Canada are provided as resources to visitors and may not represent Canada regulation or prescribing information. Lundbeck Canada accepts no responsibility in the content of linked sites.